Novartis AG
ANTI-CD40 ANTIBODIES FOR USE IN PREVENTION OF GRAFT REJECTION
Last updated:
Abstract:
The disclosure relates to methods, treatment regimens, uses, kits and therapies for preventing graft rejection in solid organ transplantation, by employing anti-CD40 antibodies.
Status:
Application
Type:
Utility
Filling date:
11 Apr 2019
Issue date:
18 Mar 2021